Valuation: Repligen Corporation

Market Cap 8.14B 7.14B 6.61B 6.08B 11.5B 779B 11.73B 78.78B 30.9B 382B 30.55B 29.88B 1,321B P/E 2026 *
132x
P/E 2027 * 80.3x
Enterprise Value 7.88B 6.91B 6.4B 5.89B 11.14B 754B 11.36B 76.31B 29.93B 370B 29.6B 28.95B 1,279B EV / Sales 2026 *
9.63x
EV / Sales 2027 * 8.17x
Free-Float
94.26%
Yield 2026 *
-
Yield 2027 * -
1 day+0.46%
1 week+2.56%
Current month+6.33%
1 month+10.86%
3 months+18.35%
6 months-13.29%
Current year-11.46%
1 week 135.08
Extreme 135.08
146.69
1 month 124.85
Extreme 124.85
149.05
Current year 100.99
Extreme 100.99
175.77
1 year 100.99
Extreme 100.99
175.77
3 years 100.99
Extreme 100.99
211.13
5 years 100.99
Extreme 100.99
327.32
10 years 25.93
Extreme 25.93
327.32
Manager TitleAgeSince
Chief Executive Officer 56 01/09/2024
Director of Finance/CFO 52 25/09/2023
Chief Tech/Sci/R&D Officer - 01/08/2025
Director TitleAgeSince
Chairman 74 14/12/2011
Director/Board Member 60 12/06/2014
Director/Board Member 67 01/10/2015
Date Insider Type Main position Quantity % Market Cap.
06-25Sell

Chief Financial Officer

-733 0.0013%
05-14Free

Director

3,234 0.0057%
05-14Free

Director

3,234 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
+0.24%+2.56%+19.57%-2.72% 8.14B
-1.44%-3.03%-29.77%-13.93% 164B
-0.21%+0.91%-6.59%-4.81% 107B
+1.08%+2.50%+3.01%+59.97% 59.04B
+2.02%-1.74%+42.83%+58.90% 51.72B
+1.00%-1.19%-13.22%-40.88% 41.87B
-0.51%-4.80% - - 34.7B
+1.67%+5.39%-10.61%-43.07% 28.93B
+1.79%+0.51%+60.12%-6.31% 24.99B
-0.12%+1.24%-4.37%-5.60% 21.05B
Average +0.59%-0.87%+6.78%+0.17% 54.14B
Weighted average by Cap. +0.05%-0.91%-4.89%+1.06%

Financials

2026 *2027 *
Net sales 818M 718M 665M 612M 1.16B 78.31B 1.18B 7.92B 3.11B 38.46B 3.07B 3.01B 133B 943M 827M 766M 705M 1.33B 90.28B 1.36B 9.13B 3.58B 44.34B 3.54B 3.46B 153B
Net income 61.09M 53.58M 49.63M 45.66M 86.37M 5.85B 88.05M 591M 232M 2.87B 229M 224M 9.92B 101M 88.74M 82.19M 75.62M 143M 9.68B 146M 980M 384M 4.76B 380M 372M 16.42B
Net Debt -254M -223M -207M -190M -360M -24.35B -367M -2.46B -966M -11.96B -955M -935M -41.3B -432M -379M -351M -323M -611M -41.34B -622M -4.18B -1.64B -20.3B -1.62B -1.59B -70.1B
Logo Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Employees
2,000
Date Price Change Volume
14/07/26 US$145.15 +0.63% 344,739
10/07/26 US$144.24 +0.21% 476,012
09/07/26 US$143.94 +4.75% 667,210
08/07/26 US$137.41 -1.73% 689,024
07/07/26 US$139.83 -1.15% 617,789
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
144.24USD
Average target price
177.05USD
Spread / Average Target
+22.75%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RGEN Stock